智通财经APP讯，普门科技(688389.SH)发布公告，近日，公司收到美国食品药品监督管理局(简称“FDA”)的通知，公司H100Plus血红蛋白检测系统获得美国FDA 510(k)准入。该产品用于体外定量检测人全血中糖化血红蛋白(HbA1c)的含量，可辅助糖尿病诊断。该产品获得美国FDA 510(k)准入，表明公司H100Plus血红蛋白检测系统符合FDA的相关要求，具备美国市场的准入资格，有利于进一步提升公司产品开拓海外市场的综合竞争力。
智通财经APP讯，普门科技(688389.SH)发布公告，近日，公司收到美国食品药品监督管理局(简称“FDA”)的通知，公司H100Plus血红蛋白检测系统获得美国FDA 510(k)准入。该产品用于体外定量检测人全血中糖化血红蛋白(HbA1c)的含量，可辅助糖尿病诊断。该产品获得美国FDA 510(k)准入，表明公司H100Plus血红蛋白检测系统符合FDA的相关要求，具备美国市场的准入资格，有利于进一步提升公司产品开拓海外市场的综合竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.